Direkt zum Inhalt
Merck
  • RNA-Seq Analysis of the Host Response to Staphylococcus aureus Skin and Soft Tissue Infection in a Mouse Model.

RNA-Seq Analysis of the Host Response to Staphylococcus aureus Skin and Soft Tissue Infection in a Mouse Model.

PloS one (2015-04-23)
Rebecca A Brady, Vincent M Bruno, Drusilla L Burns
ZUSAMMENFASSUNG

Staphylococcus aureus is a leading cause of skin and soft tissue infections (SSTI), which are primarily self-limiting. We conducted a comprehensive analysis of the host transcriptome during a S. aureus SSTI to provide insight on the protective mechanisms that thwart these infections. We utilized a murine SSTI model in which one ear is epicutaneously challenged while the other is not. We then harvested these infected and uninfected ears, as well as ears from naïve mice, at one, four, and seven days post-challenge, and performed RNA sequencing (RNA-seq) using the Illumina platform. RNA-seq data demonstrated a robust response at the site of infection. Comparison of gene expression profiles between infected ears and the non-infected ears of challenged mice defined the local response to infection, while comparisons of expression profiles of non-infected ears from challenged mice to ears of naïve mice revealed changes in gene expression levels away from the site indicative of a systemic response. Over 1000 genes exhibited increased expression locally at all tested time points. The local response was more robust than the systemic response. Through evaluation of the RNA-seq data using the Upstream Regulator Analytic as part of the Ingenuity Pathway Analysis software package, we found that changes in the activation and inhibition of regulatory pathways happen first locally, and lag behind systemically. The activated pathways are highly similar at all three time points during SSTI, suggesting a stable global response over time. Transcript increases and pathway activation involve pro- and anti-inflammatory mediators, chemotaxis, cell signaling, keratins, and TH1/TH17 cytokines. Transcript decreases and pathway inhibition demonstrate that metabolic genes and anti-inflammatory pathways are repressed. These data provide insight on the host responses that may aid in resolution of this self-limited S. aureus infection, and may shed light on potential immune correlates of protection for staphylococcal SSTI.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Diethylpyrocarbonat, 96% (NT)
Sigma-Aldrich
Hydrocortison, BioReagent, suitable for cell culture
Sigma-Aldrich
Hydrocortison, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Hydrocortison, ≥98% (HPLC)
Sigma-Aldrich
Progesteron, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Indol, ≥99%
Sigma-Aldrich
Progesteron, ≥99%
Sigma-Aldrich
Diethylpyrocarbonat, 96% (NT)
Sigma-Aldrich
Diethylpyrocarbonat, 96% (NT)
Sigma-Aldrich
Progesteron, meets USP testing specifications
Sigma-Aldrich
Xylazin, ≥99%
Sigma-Aldrich
Indol, ≥99%, FG
USP
Hydrocortison, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
DL-Cystein, technical grade
Sigma-Aldrich
Progesteron, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
DL-Serin, ≥98% (TLC)
USP
Progesteron, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Hydrocortison, meets USP testing specifications
Sigma-Aldrich
DL-Serin, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98% (HPLC)
Sigma-Aldrich
2,2′-Bichinolin-4,4′-dicarbonsäure Dinatriumsalz Dihydrat, ≥98% (HPLC)
Sigma-Aldrich
β-D-Allose, rare aldohexose sugar
Supelco
Hydrocortison, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Progesteron, Pharmaceutical Secondary Standard; Certified Reference Material
Serin, European Pharmacopoeia (EP) Reference Standard
Progesteron für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Progesteron für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Progesteron, European Pharmacopoeia (EP) Reference Standard
Hydrocortison, European Pharmacopoeia (EP) Reference Standard
Hydrocortison, British Pharmacopoeia (BP) Assay Standard
Hydrocortison für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard